Csurhes PA, Sullivan A-A, Green K, Greer JM, Pender MP, McCombe PA (2005) Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome. J Clin Neurosci 12(4):409–415
CAS
Article
PubMed
Google Scholar
Gaudy-Marqueste C, Monestier S, Franques J, Cantais E, Richard M-A, Grob J-J (2013) A severe case of ipilimumab-induced guillain–barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis. J Immunother 36(1):77–78
Article
PubMed
Google Scholar
Naidoo J, Page D, Li B et al (2015) Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 26(12):2375–2391
CAS
PubMed
Google Scholar
Wilgenhof S, Neyns B (2011) Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patient. Ann Oncol 22(4):991–993
CAS
Article
PubMed
Google Scholar
Yuki N, Hartung H-P (2012) Guillain–Barré syndrome. N Engl J Med 366(24):2294–2304
CAS
Article
PubMed
Google Scholar